These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23815562)

  • 1. Evaluation of safety and efficacy of a fixed olmesartan/amlodipine combination therapy compared to single monotherapies.
    Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
    Expert Opin Drug Saf; 2013 Sep; 12(5):621-9. PubMed ID: 23815562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olmesartan/amlodipine combination versus olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patients.
    Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
    Clin Exp Hypertens; 2013; 35(5):301-7. PubMed ID: 22954201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammation.
    Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
    Eur J Pharm Sci; 2014 Jan; 51():26-33. PubMed ID: 23999037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an olmesartan/amlodipine fixed dose on blood pressure control, some adipocytokines and interleukins levels compared with olmesartan or amlodipine monotherapies.
    Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
    J Clin Pharm Ther; 2013 Feb; 38(1):48-55. PubMed ID: 23216584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapies.
    Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
    J Am Soc Hypertens; 2013; 7(1):32-9. PubMed ID: 23321403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Prospective Randomized, Double-Blind, Multi-Center, Phase III Clinical Trial Evaluating the Efficacy and Safety of Olmesartan/Amlodipine plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia: A LEISURE Study.
    Jo SH; Kang SM; Yoo BS; Lee YS; Youn HJ; Min K; Yu JM; Yoon HJ; Kim WS; Kim GH; Park JH; Kim SY; Kim CH
    J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients.
    Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
    Inflammation; 2014 Feb; 37(1):154-62. PubMed ID: 24018781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of the single-pill combination of aliskiren 300 mg/amlodipine 10 mg in hypertensive patients not controlled by olmesartan 40 mg/amlodipine 10 mg.
    Axthelm C; Sieder C; Meister F; Kaiser E
    Curr Med Res Opin; 2012 Jan; 28(1):69-78. PubMed ID: 22117838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes.
    Redon J; Pichler G;
    J Hypertens; 2016 Feb; 34(2):359-67. PubMed ID: 26867060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of olmesartan medoxomil plus amlodipine in age, gender and hypertension severity defined subgroups of hypertensive patients.
    Schmieder RE; Böhm M
    J Hum Hypertens; 2011 Jun; 25(6):354-63. PubMed ID: 20686499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subgroup analyses of an efficacy and safety study of concomitant administration of amlodipine besylate and olmesartan medoxomil: evaluation by baseline hypertension stage and prior antihypertensive medication use.
    Oparil S; Lee J; Karki S; Melino M
    J Cardiovasc Pharmacol; 2009 Nov; 54(5):427-36. PubMed ID: 19730391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of olmesartan medoxomil/amlodipine fixed-dose combination for hypertensive patients uncontrolled with monotherapy.
    Zhu JR; Zhang SY; Gao PJ
    Arch Pharm Res; 2014 Dec; 37(12):1588-98. PubMed ID: 25060946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of olmesartan/amlodipine combination therapy in reducing ambulatory blood pressure in moderate-to-severe hypertensive patients not controlled by amlodipine alone.
    Bilo G; Koch W; Hoshide S; Parati G
    Hypertens Res; 2014 Sep; 37(9):836-44. PubMed ID: 24942766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Fixed-Dose Perindopril Arginine/Amlodipine in Hypertensive Patients Not Adequately Controlled with Amlodipine 5 mg or Perindopril tert-Butylamine 4 mg Monotherapy.
    Hu D; Sun Y; Liao Y; Huang J; Zhao R; Yang K
    Cardiology; 2016; 134(1):1-10. PubMed ID: 26771522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension.
    Chrysant SG
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):887-95. PubMed ID: 19673666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
    Kereiakes DJ; Neutel JM; Punzi HA; Xu J; Lipka LJ; Dubiel R
    Am J Cardiovasc Drugs; 2007; 7(5):361-72. PubMed ID: 17953475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
    Derosa G; Cicero AF; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Fassi R; Fogari R
    Clin Ther; 2007 Apr; 29(4):602-10. PubMed ID: 17617283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effects of combined olmesartan medoxomil and amlodipine on clinic and ambulatory blood pressure in elderly patients with resistant hypertension.
    Ding S; Liu J; Fu Q; Zheng Y
    Arch Gerontol Geriatr; 2013; 57(3):423-7. PubMed ID: 23669062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
    Punzi HA
    Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.